Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

Journal:

The Lancet Oncology

Published:

2025-07-08

DOI:

10.1016/s1470-2045(25)00231-1

Affiliations:

39

Authors:

4229

Go to article

Institutions	Authors	Share
MRC Clinical Trials Unit (CTU), United Kingdom (UK)	16.500000 16.500000	0.31
The Christie NHS Foundation Trust, United Kingdom (UK)	3.500000	0.07
The University of Manchester (UoM), United Kingdom (UK)	2.833333	0.05
The Institute of Cancer Research (ICR), United Kingdom (UK)	2.333333	0.04
The Royal Marsden Hospital - London, The Royal Marsden NHS Foundation Trust, United Kingdom (UK)	1.833333	0.03
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)	1.500000	0.03
University of Glasgow, United Kingdom (UK)	1.500000	0.03
UCL, United Kingdom (UK)	1.500000	0.03
Royal Devon and Exeter Hospital, United Kingdom (UK)	1.000000	0.02
Queen Alexandra Hospital, United Kingdom (UK)	1.000000	0.02
University of Wolverhampton, United Kingdom (UK)	1.000000	0.02
Salford Royal Hospital, United Kingdom (UK)	1.000000	0.02
Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
St James's University Hospital, United Kingdom (UK)	1.000000	0.02
The Clatterbridge Cancer Centre NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Royal Blackburn Hospital, East Lancashire Hospitals NHS Trust, United Kingdom (UK)	1.000000	0.02
Nottingham University Hospitals NHS Trust (NUH), United Kingdom (UK)	1.000000	0.02
Velindre Cancer Centre, Velindre NHS Trust, United Kingdom (UK)	1.000000	0.02
Airedale NHS Foundation Trust, United Kingdom (UK)	1.000000	0.02
Royal Shrewsbury Hospital, SaTH NHS Trust, United Kingdom (UK)	1.000000	0.02
Cardiff University, United Kingdom (UK)	1.000000	0.02
Calderdale and Huddersfield NHS Foundation, United Kingdom (UK)	1.000000	0.02
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), United Kingdom (UK)	1.000000	0.02
Airedale General Hospital, United Kingdom (UK)	1.000000	0.02
Swiss Group for Clinical Cancer Research (SAKK), Switzerland	0.833333	0.02
Oncology Institute of Southern Switzerland (IOSI), Switzerland	0.833333	0.02
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK)	0.500000	0.01
The Royal Marsden Hospital (Surrey), United Kingdom (UK)	0.500000	0.01
Beatson West of Scotland Cancer Centre (BWoSCC), United Kingdom (UK)	0.500000	0.01
Royal Devon University Healthcare NHS Foundation Trust, United Kingdom (UK)	0.500000	0.01
University of Exeter, United Kingdom (UK)	0.500000	0.01
Università della Svizzera Italiana (USI), Switzerland	0.333333	0.01
University of Lancashire, United Kingdom (UK)	0.333333	0.01
The Royal Marsden NHS Foundation Trust, United Kingdom (UK)	0.333333	0.01
Lancashire Teaching Hospitals NHS Foundation Trust, United Kingdom (UK)	0.333333	0.01

Interested in Oncology and Carcinogenesis?